Ganendra Raj Mohan
Overview
Explore the profile of Ganendra Raj Mohan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang E, Weir A, Meagher N, Farrington K, Nelson G, Ghatage P, et al.
Cancer
. 2022 Dec;
129(5):697-713.
PMID: 36572991
Background: Cyclin E1 (CCNE1) is a potential predictive marker and therapeutic target in tubo-ovarian high-grade serous carcinoma (HGSC). Smaller studies have revealed unfavorable associations for CCNE1 amplification and CCNE1 overexpression...
2.
Meagher N, Gorringe K, Wakefield M, Bolithon A, Pang C, Chiu D, et al.
Clin Cancer Res
. 2022 Oct;
28(24):5383-5395.
PMID: 36222710
Purpose: Advanced-stage mucinous ovarian carcinoma (MOC) has poor chemotherapy response and prognosis and lacks biomarkers to aid stage I adjuvant treatment. Differentiating primary MOC from gastrointestinal (GI) metastases to the...
3.
Ching D, Soma A, Khor T, Mohan G, Stewart C
Pathology
. 2021 Jul;
54(1):136-138.
PMID: 34253373
No abstract available.
4.
Gupta S, Nichols C, Phillips J, OSullivan S, Ayres C, Mohan G, et al.
Int J Gynecol Cancer
. 2021 Apr;
31(6):846-851.
PMID: 33858951
Background: In 2016 universal screening with mismatch repair protein immunohistochemistry in all newly diagnosed endometrial carcinomas was introduced in Western Australia. Objective: To compare the prevalence of Lynch syndrome associated...
5.
Rajadurai V, Chivers P, Ayres C, Mohan G, Stewart C, Leung Y, et al.
Aust N Z J Obstet Gynaecol
. 2021 Jan;
61(2):275-283.
PMID: 33403680
Aim: Our objective was to assess clinical and pathological factors associated with a final diagnosis of endometrial carcinoma in patients with atypical endometrial hyperplasia with a particular emphasis on the...
6.
Cohen P, Leung Y, Anderson L, van der Griend R, Chivers P, Bilic S, et al.
Gynecol Oncol
. 2020 Oct;
159(3):623-629.
PMID: 33032824
Objective: Adenocarcinoma in situ (AIS) of the cervix is a precursor to cervical adenocarcinoma. When AIS is detected by cervical screening an excision biopsy is mandatory to exclude invasion. We...
7.
Standen P, Cohen P, Leung Y, Mohan G, Salfinger S, Tan J, et al.
Asian Pac J Cancer Prev
. 2020 Sep;
21(9):2609-2614.
PMID: 32986359
Background: Approximately 20% of women with gynecologic cancers are under age 40 and with delayed childbearing, women may be diagnosed before their first pregnancy. Although fertility preservation is a priority...
8.
Hardcastle S, Galliott M, Lynch B, Nguyen N, Cohen P, Mohan G, et al.
Int J Behav Med
. 2019 Aug;
26(5):551-561.
PMID: 31364038
Background: There are significant geographic inequalities in cancer survival with poorer survival rates in non-metropolitan areas compared to major cities. Physical activity (PA) can reduce cancer recurrence and prevent cardiovascular...
9.
Hardcastle S, Hince D, Jimenez-Castuera R, Boyle T, Cavalheri V, Makin G, et al.
BMJ Open
. 2019 May;
9(5):e028369.
PMID: 31129600
Introduction: Physically active cancer survivors have substantially less cancer recurrence and improved survival compared with those who are inactive. However, the majority of survivors (70%-90%) are not meeting the physical...
10.
Hardcastle S, Galliott M, Lynch B, Nguyen N, Cohen P, Mohan G, et al.
PLoS One
. 2019 Jan;
13(12):e0210039.
PMID: 30596781
Purpose: The study purpose was to investigate the acceptability and utility of, and preference for, wearable activity trackers (WATs) amongst cancer survivors living in regional and remote areas of Western...